1. Chemotherapy-induced peripheral neuropathy: An increasing concern for oncologists

   • Maurie Markman

   Editor’s Commentary Pages: 159 - 160

2. Web alert

   News Pages: 161 - 163

3. First-line therapy for advanced colorectal cancer

   • Aimery de Gramont
   • Christophe Tournigand
   • Thierry André

   OriginalPaper Pages: 167 - 172

4. Second-line therapy for advanced colorectal carcinoma

   • Naureen Starling
   • David Cunningham

   OriginalPaper Pages: 173 - 180

5. Adjuvant therapy for colon cancer

   • Weijing Sun
   • Daniel G. Haller

   OriginalPaper Pages: 181 - 185

6. Chemotherapy for advanced pancreatic cancer: Past, present, and future

   • Gregory Friberg
   • Hedy Lee Kindler

   OriginalPaper Pages: 186 - 195

7. Chemoradiotherapy for gastrointestinal cancers

   • Tyvin A. Rich
   • Christopher Crane
   • Jerome Landry

   OriginalPaper Pages: 196 - 202

8. Docetaxel-based chemotherapy trials in androgen-independent prostate cancer: First demonstration of a survival benefit

   • Daniel P. Petrylak

   Clinical Trials Report Pages: 205 - 206

9. Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials

   • Michelle Boyar
   • Daniel P. Petrylak

   OriginalPaper Pages: 207 - 214

10. Angiogenesis and prostate cancer: Important laboratory and clinical findings

    • Michael C. Cox
    • Matthew Permenter
    • William D. Figg

    OriginalPaper Pages: 215 - 219

11. Chemotherapy for advanced prostate cancer: Results of new clinical trials and future studies

    • Andrew J. Armstrong
    • Michael A. Carducci

    OriginalPaper Pages: 220 - 227

12. Secondary hormonal manipulations in prostate cancer

    • Charles J. Ryan
    • Eric J. Small

    OriginalPaper Pages: 228 - 233